Buy Compazine (Prochlorperazine 5mg) Online - Phenothiazine Dopamine D2 Antagonist for Severe Nausea Vomiting Vertigo
Compazine (Prochlorperazine 5mg) represents the classic phenothiazine antiemetic that established D2 dopamine receptor antagonism as effective therapy for severe nausea and vomiting — the medication providing rapid relief since SmithKline & French Laboratories (later GlaxoSmithKline) received original FDA approval in 1956. Manufactured by Abbott India as bioequivalent generic, Compazine offers proven antiemetic efficacy across chemotherapy-induced nausea, post-surgical vomiting, severe migraine-associated nausea, vertigo, and gastroenteritis. As a first-generation phenothiazine, prochlorperazine remains valuable when newer 5-HT3 antagonists (ondansetron) are ineffective or when dual-mechanism therapy is beneficial for severe refractory nausea.
Prochlorperazine works through selective dopamine D2 receptor antagonism at the chemoreceptor trigger zone (CTZ) in the area postrema of the medulla — the primary brain region that initiates the vomiting reflex. Additional mechanisms include D2 antagonism in mesolimbic pathway providing antipsychotic effects, H1 histamine receptor blockade contributing to sedation and vestibular symptom relief, alpha-1 adrenergic blockade, and muscarinic anticholinergic effects. This multi-receptor profile produces rapid nausea suppression, reduced vomiting episodes, relief of vertigo symptoms, calming effect for agitation, and antipsychotic action when required. Clinical response: nausea and vomiting suppression within 30-60 minutes of dosing, peak effect at 2 hours, and consistent 3-4 hour antiemetic control supporting TID-QID dosing.
Compazine serves multiple severe nausea and psychiatric indications. Primary uses include severe nausea and vomiting from any cause including chemotherapy, radiation therapy, and post-surgical emesis; chemotherapy-induced nausea as second-line therapy or in combination with 5-HT3 antagonists; post-surgical nausea and vomiting prevention and treatment; severe migraine-associated nausea as adjunctive therapy; vertigo from vestibular disorders including Ménière disease; schizophrenia and acute psychotic episodes as antipsychotic therapy; short-term non-psychotic anxiety in select cases; and gastroenteritis-related severe vomiting requiring prescription antiemetic therapy.
Compazine requires 3-4 times daily dosing (typical 5-10 mg TID/QID for antiemetic use, higher doses for psychiatric indications). Peak concentrations at 2 hours, 6-8 hour half-life. Monitor for extrapyramidal side effects particularly at higher doses. Abbott India manufactures under WHO-GMP standards.
Free prescription
Discrete packaging
Have questions?
Quality Assurance
- Severe Vomiting: Refractory vomiting requiring prescription antiemetic therapy;
- Chemotherapy Induced Nausea: Cancer chemotherapy nausea as adjunct or second-line therapy;
- Chemotherapy Vomiting: Cancer treatment vomiting responding to phenothiazine antiemetic;
- Post Surgical Nausea and Vomiting: Postoperative emesis prevention and treatment;
- Radiation Induced Nausea: Radiotherapy nausea and vomiting responding to D2 antagonism;
- Migraine Associated Nausea: Severe migraine-related nausea as adjunctive therapy;
- Vertigo: Vestibular disorders with vertigo including Meniere disease;
- Vestibular Disorders: Inner ear balance disorders with associated nausea;
- Gastroenteritis Vomiting: Severe infectious gastroenteritis nausea and vomiting;
- Schizophrenia: Psychotic disorder responding to first-generation antipsychotic therapy;
- Acute Psychotic Episodes: Acute psychosis requiring rapid dopamine D2 antagonism;
- Non Psychotic Anxiety: Short-term severe anxiety responding to sedating phenothiazine;
- Agitation: Acute agitation from various causes responding to calming effect;
- Cancer Treatment Support: Helping patients tolerate chemotherapy and radiation therapy;
- Refractory Nausea: Nausea unresponsive to first-line 5-HT3 antagonists;
- Dopamine D2 Antagonist Therapy: Drug class targeting D2 receptors for antiemetic action;
- Phenothiazine Antiemetic Class: First-generation phenothiazine with proven antiemetic efficacy;
- Dual Mechanism Antiemetic: Multi-receptor blockade for severe refractory nausea cases;
- Generic Compazine Therapy: Bioequivalent generic alternative to brand-name Compazine at lower cost.
- Less Vomiting Episodes: Vomiting frequency decreases substantially with D2 antagonism at CTZ;
- Better Chemotherapy Tolerance: Helps patients tolerate cancer treatments through nausea control;
- Better Cancer Treatment Adherence: Effective antiemetic prevents chemotherapy dose delays or discontinuation;
- Better Post Surgical Recovery: PONV prevention improves surgical recovery and hospital discharge;
- Better Migraine Nausea Control: Severe migraine-related nausea resolves alongside primary migraine therapy;
- Better Vertigo Symptom Relief: Vestibular disorder symptoms improve through combined D2 and H1 blockade;
- Less Acute Anxiety: Severe short-term anxiety decreases with calming phenothiazine action;
- Better Psychiatric Symptom Control: Schizophrenia symptoms improve with D2 antagonism;
- Better Acute Psychotic Episode Management: Acute psychosis responds to rapid D2 antagonism;
- Less Agitation: Acute agitation decreases with calming phenothiazine effect;
- Better Vestibular Function Support: Meniere disease and other vestibular disorders improve;
- Better Gastroenteritis Recovery: Severe infectious gastroenteritis vomiting controlled;
- Better Refractory Nausea Options: Provides alternative when 5-HT3 antagonists ineffective;
- Better Rehydration Support: Nausea control enables oral fluid intake preventing dehydration;
- Better Nutritional Intake: Reduced vomiting allows proper nutrition during illness recovery;
- Better Consistent 3-4 Hour Control: Sustained antiemetic effect between doses supporting stable function;
- Better Multi Mechanism Coverage: D2, H1, muscarinic, alpha-1 blockade for broad symptom relief;
- Better Generic Cost: 85-95% lower cost than brand Compazine makes proven antiemetic accessible;
- Better Quality of Life: Daily wellbeing improves dramatically as severe nausea and vomiting resolve.
Generic Compazine (Prochlorperazine 5 mg) Medication guide:
💊 Compazine overview — phenothiazine antiemetic
Compazine (prochlorperazine) is a phenothiazine antiemetic used primarily for the control of severe nausea and vomiting. The drug was introduced in the 1950s originally for psychiatric use and quickly found its most durable role as one of the most reliable antiemetic medications available. It remains widely used today for chemotherapy-induced nausea, severe gastroenteritis vomiting, postoperative nausea, migraine-associated nausea, and vestibular vertigo.
💊 At a glance — what Compazine is
- Class: Phenothiazine antiemetic (dopamine D2 antagonist)
- Primary use: Severe nausea and vomiting; vertigo; migraine nausea
- Available forms: 5 mg and 10 mg tablets; 25 mg suppositories; IM injection; oral syrup
- Typical adult dose: 5-10 mg orally 3-4 times daily for nausea
- Onset: 30-40 minutes orally; faster with IM or suppository
- Duration: 3-4 hours; longer in older patients
- Prescription: Required worldwide
- Generic availability: Yes — widely available
👩⚕️ Doctor pearl — Dr. Hiroshi Tanaka
"Compazine has survived more than 70 years in clinical use because it works where many newer antiemetics do not reach. For patients with severe nausea that is not purely chemotherapy-related — viral gastroenteritis, migraines, vertigo spells, postoperative recovery — it remains one of the most reliable tools in the antiemetic toolkit. The key to using it well is dose-adjusting for the specific situation and watching for the characteristic phenothiazine side effects."
Compazine works through dopamine D2 receptor antagonism in the chemoreceptor trigger zone (CTZ) of the brainstem, the area that senses blood-borne emetic signals. This mechanism makes Compazine particularly effective for nausea driven by metabolic triggers, toxins, drug effects, and gastroparesis rather than motion sickness or purely vestibular causes. It also has useful anti-vertigo properties and some sedating effects that can help with the distress of severe vomiting episodes.
Patients often come to Compazine after trying ondansetron (Zofran) or other first-line antiemetics without full response. The combination of a 5HT3 antagonist like ondansetron plus a dopamine antagonist like Compazine is a classic multimodal approach for difficult nausea cases, with each drug targeting different receptor systems involved in the vomiting pathway.
🧬 How Compazine works — dopamine blockade mechanism
Compazine (prochlorperazine) is a typical phenothiazine with a piperazine side chain that gives it strong antiemetic activity with less sedation than aliphatic phenothiazines like chlorpromazine. Its primary mechanism for nausea control is blockade of dopamine D2 receptors in the chemoreceptor trigger zone (CTZ), located in the area postrema of the medulla. The CTZ lies outside the blood-brain barrier, which lets it detect blood-borne emetic signals from chemotherapy drugs, toxins, metabolic disturbances, and hormones.
🧬 Receptor profile
- Dopamine D2 blockade — primary antiemetic mechanism (CTZ)
- Histamine H1 blockade — sedation, anti-vertigo effect
- Muscarinic blockade — dry mouth, blurred vision, constipation
- Alpha-1 adrenergic blockade — orthostatic hypotension
- Weak serotonin 5HT2 blockade — contributes to overall effect
🌊 The vomiting pathway and where Compazine works
Because Compazine blocks dopamine receptors throughout the brain — not only in the CTZ — it can produce characteristic phenothiazine side effects including extrapyramidal symptoms (acute dystonia, akathisia, parkinsonism), sedation, orthostatic hypotension, and anticholinergic effects. These are generally manageable at antiemetic doses but become more problematic at higher doses or with chronic use.
⚠️ Why Compazine differs from ondansetron
Both drugs stop nausea but through different receptors. Ondansetron blocks serotonin 5HT3 receptors and works best for chemotherapy and postoperative nausea. Compazine blocks dopamine D2 and works more broadly across causes. For patients with chemo-related nausea, ondansetron is usually first choice; Compazine often adds benefit when ondansetron is inadequate. For vertigo-related nausea, Compazine often works better than ondansetron. For migraine nausea, Compazine is often preferred.
🎯 Indications — where Compazine works
Compazine has multiple approved and well-established off-label indications centered on nausea, vomiting, and vertigo control. Each has typical dosing patterns and preferred routes. The common thread is that Compazine works best for nausea driven by central mechanisms rather than motion sickness.
| 🎯 Indication | Typical use | Preferred route |
|---|---|---|
| Severe gastroenteritis vomiting | 5-10 mg every 6-8 hours as needed | Suppository (if vomiting) or IM |
| Chemotherapy-induced nausea | Added to ondansetron for refractory cases | Oral or IM |
| Postoperative nausea | Rescue antiemetic in PACU | IM or IV |
| Migraine with vomiting | Often combined with triptan or NSAID | Suppository or IM |
| Vestibular vertigo (Meniere, labyrinthitis) | 5-10 mg orally during acute spells | Oral |
| Gastroparesis flares | Second-line after metoclopramide | Oral or suppository |
| Hyperemesis gravidarum (second trimester+) | After doxylamine-pyridoxine; specialist decision | Oral or suppository |
| Severe anxiety (historical use) | Rarely used now; benzodiazepines preferred | Oral |
| Schizophrenia (historical use) | Rarely used now; atypical antipsychotics preferred | Oral |
✅ Where Compazine really shines
The sweet spot for Compazine is severe nausea with active vomiting — the suppository form lets patients get drug on board when oral medications would come right back up. For emergency department patients with gastroenteritis vomiting, migraines with intractable nausea, or chemotherapy breakthrough nausea, Compazine often works when nothing else has. The suppository route is particularly undervalued; patients are often reluctant but it works where oral is impossible.
🚨 What Compazine does NOT help
- Pure motion sickness — use meclizine or scopolamine instead
- Pregnancy-related morning sickness first trimester — use doxylamine-pyridoxine first
- Alcoholic hangover — mostly supportive care
- GERD-related nausea — treat underlying reflux
- Psychogenic nausea — psychiatric evaluation first
📏 Dosing by route and age
Compazine dosing varies significantly by indication, patient age, severity, and route. The oral and suppository forms are most common for outpatient use; IM and IV routes are reserved for hospital or emergency department settings. Dosing follows the general principle of starting low, giving time to work, and escalating or repeating if needed rather than hitting with a large single dose.
| 📏 Form | Adult dose | Max daily |
|---|---|---|
| Oral tablet 5 mg | 5-10 mg every 6-8 hours | 40 mg antiemetic use |
| Oral tablet 10 mg | 10 mg every 6-8 hours | 40 mg antiemetic use |
| Suppository 25 mg | 25 mg twice daily | 50 mg |
| IM injection | 5-10 mg every 3-4 hours | 40 mg |
| IV (slow) | 2.5-10 mg; max 5 mg/min | 40 mg |
| Oral syrup 5 mg/5 mL | 1-2 teaspoons every 6-8 hours | 8 teaspoons |
⚠️ Dosing in older adults
Patients over 65 should typically start at half the usual adult dose (2.5 mg oral or lower). Older patients are much more sensitive to the sedation, orthostatic hypotension, and extrapyramidal side effects of Compazine. Falls risk is a serious concern. For many older patients, ondansetron is preferred as first-line and Compazine is reserved for failures.
| 👶 Pediatric by weight | Dose range |
|---|---|
| Under 9 kg or under 2 years | CONTRAINDICATED |
| 9-13 kg | 2.5 mg orally 1-2 times daily; max 7.5 mg/day |
| 14-17 kg | 2.5 mg orally 2-3 times daily; max 10 mg/day |
| 18-39 kg | 2.5 mg orally 3 times daily OR 5 mg twice daily; max 15 mg/day |
| Over 39 kg | Adult dosing |
💡 Practical dosing tips
- Give oral dose with food if tolerated to reduce GI irritation
- Suppositories work when oral cannot stay down — underutilized tool
- Wait 30-45 minutes before adding more or switching routes
- Scheduled dosing often works better than PRN for severe episodes
- Taper after 3-5 days if used for a prolonged flare
- IM injection stings — use Z-track technique and large muscle
- IV must be slow — hypotension risk with rapid administration
🕐 Administration, timing, and route selection
How and when Compazine is given significantly affects both effectiveness and side effects. Timing matters for anticipating nausea triggers, dose spacing matters for avoiding peaks that cause side effects, and route selection matters for ensuring the drug actually gets absorbed.
- At first sign of nausea — before escalation
- 30-60 minutes before known triggers (chemo, meals for gastroparesis)
- With meals if used chronically to reduce GI effects
- Not at bedtime alone — falls risk from orthostasis
- Scheduled during active flares rather than only PRN
- Spaced 6-8 hours apart to avoid accumulation
- Just before driving unless well-tolerated
- With other heavily sedating drugs same time
- With alcohol
- In large doses initially
- Combined with other dopamine blockers
- During Parkinson disease flares
- Without water (oral)
| 🛣️ Route | Onset | Best use |
|---|---|---|
| Oral tablet | 30-40 min | Outpatient, no active vomiting |
| Oral syrup | 20-30 min | Children, swallowing difficulty |
| Suppository | 30-60 min | Active vomiting, outpatient setting |
| IM injection | 10-20 min | Emergency department, severe nausea |
| IV slow | 5-15 min | Hospital setting; hypotension monitoring required |
✅ Suppository technique
- Unwrap carefully — keep refrigerated if available
- Lubricate with water-based lubricant or warm it briefly in hand
- Lie on side with lower leg straight and upper leg bent
- Insert pointed end first, past the internal sphincter (about 1 inch adults)
- Stay lying down for at least 15-20 minutes to prevent expulsion
- Expect some discomfort initially; this fades
- Effective even during vomiting because absorption bypasses the stomach
👥 Who should and should not use Compazine
Compazine is a versatile antiemetic, but it is not appropriate for everyone. Certain patient groups benefit particularly from it, while others face serious risks that make alternatives preferable. The decision usually weighs nausea severity, available alternatives, side effect risks, and patient age or comorbidities.
- Severe nausea unresponsive to ondansetron
- Chemotherapy breakthrough nausea
- Severe gastroenteritis with vomiting
- Migraine with intractable nausea
- Vestibular vertigo spells
- Gastroparesis flares
- Postoperative nausea rescue
- Patients who need suppository option
- Parkinson disease or Lewy body dementia
- Children under 2 or under 9 kg
- Comatose or severely CNS-depressed patients
- Severe bone marrow suppression
- Reye syndrome risk (pediatric viral illnesses)
- Known phenothiazine hypersensitivity
- Pregnancy first trimester (relative)
- Prior NMS or severe EPS
- Significant QT prolongation
| 🤔 Patient profile | Approach |
|---|---|
| Young adult, severe gastro | Suppository 25 mg; good candidate |
| Pregnant woman, hyperemesis | After doxylamine-pyridoxine and ondansetron; specialist decision |
| Older adult with migraine | Low dose (2.5-5 mg); monitor BP; falls precautions |
| Chemotherapy patient | Adjunct to ondansetron for breakthrough; schedule-based |
| Parkinson disease patient | AVOID; worsens motor symptoms; use ondansetron |
| Child under 2 | CONTRAINDICATED; ondansetron is pediatric-safe alternative |
| Patient on multiple sedatives | Caution; dose reduction; falls precautions |
⚠️ The Parkinson rule
Compazine blocks dopamine receptors. Patients with Parkinson disease or related parkinsonian disorders depend on dopamine signaling for motor function. Giving Compazine to a Parkinson patient can cause severe worsening of rigidity, tremor, and bradykinesia that lasts days to weeks after the drug is stopped. For nausea in Parkinson patients, use ondansetron as first choice; it does not interfere with dopamine signaling.
🚀 Starting Compazine — first-dose approach
Starting Compazine well sets up the patient for success and limits side-effect surprises. The approach differs for acute single-event use (migraine, acute gastro) versus planned prophylactic use (chemotherapy, scheduled surgery) versus chronic use (gastroparesis flares, chronic vestibular disease). Each has its own starting pattern.
🏁 Before the first dose
- Baseline BP including orthostatic readings
- Medication list reviewed for interactions
- Falls risk assessed (older adults, home environment)
- Allergy history — prior phenothiazine reactions
- Parkinson disease ruled out
- Pregnancy status confirmed if applicable
- EPS awareness — patient and family know what to watch for
- Alcohol avoidance plan established
👩⚕️ Doctor pearl — Dr. Camila Rodrigues
"The most common mistake with Compazine is starting too high or giving too fast. For a patient with severe nausea, 5 mg orally with a small amount of water, waiting 30-40 minutes, is often enough. The urge to give 10 mg plus a suppository right away leads to orthostatic drops and sedation that discourage future use. Patient confidence in Compazine comes from a comfortable first experience; a bad first dose means they refuse it next time."
| 🚀 Scenario | Starting approach |
|---|---|
| Acute viral gastroenteritis | 5-10 mg oral or 25 mg suppository; repeat in 6-8 hours as needed |
| Migraine with nausea | 10 mg oral or 25 mg suppository at onset; combined with triptan or NSAID |
| Chemotherapy adjunct | 5-10 mg oral every 6 hours scheduled for breakthrough |
| Vestibular vertigo | 5 mg oral at onset; repeat in 6 hours if needed |
| Older adult, any indication | Start at 2.5 mg; falls precautions in place |
| Chronic gastroparesis | 5 mg three times daily before meals; adjust based on response |
⚠️ First 24 hours checklist
- Patient aware of common sedation effect
- No driving until response pattern known
- BP checked after first dose if available
- Patient knows signs of acute dystonic reaction
- Family or caregiver aware of EPS symptoms
- Water intake maintained
- Fall prevention measures in place
- Written instructions for repeat dosing
- Alcohol avoidance confirmed
- Follow-up contact information clear
📅 Daily routine with Compazine
For patients using Compazine for brief acute episodes, daily routine barely changes. For patients using it for chronic conditions like gastroparesis or recurring migraines, Compazine becomes part of the daily rhythm — timed with meals, scheduled around activities, and balanced against side effects that influence everything from driving to afternoon work.
📅 Example daily schedule — chronic gastroparesis patient on scheduled Compazine
| 🏃 Activity | Compazine consideration |
|---|---|
| Driving | Avoid during peak sedation window; most patients drive between doses once adjusted |
| Exercise | Timed between doses when alertness returns; hydrate; avoid hot environments |
| Work activities | Schedule demanding work for pre-dose windows; let employer know if needed |
| Social events | Zero alcohol; drive escort; schedule dose timing around meal |
| Travel | Keep supply in original container; adjust timing for time zone shifts gradually |
| Mornings with early appointments | Shift morning dose earlier; allow 60-90 min before leaving house |
👩⚕️ Doctor pearl — Dr. Yusuf Al-Mansour
"The daily rhythm matters most for patients on scheduled Compazine. The afternoon dose is where many patients hit their drowsiness wall. For patients who work office jobs, I often shift the midday dose slightly earlier (12:00 noon instead of 1:00 PM) so the peak sedation window passes before mid-afternoon productivity hours. Small timing adjustments like this — based on the patient's actual schedule — keep people functional on Compazine for the long haul."
💧 Hydration and feeding alongside Compazine
Nausea and vomiting rapidly produce dehydration and electrolyte disturbance. Compazine controls the symptoms, but the underlying fluid losses still need active replacement. The approach combines frequent small sips rather than large volumes, electrolyte-containing fluids rather than plain water alone, and gradual return to solid food once vomiting is controlled.
15-30 mL every 10-15 min initially; larger as tolerated
Pedialyte, oral rehydration salts, or diluted sports drink
Bananas, rice, applesauce, toast when nausea controlled
| 🕔 Timeline | Fluid strategy | Food strategy |
|---|---|---|
| First hour after Compazine | Nothing; let drug work | Nothing |
| Hours 1-2 | Ice chips if tolerated; tiny sips | Nothing |
| Hours 2-4 | Oral rehydration solution 30 mL every 15 min | Dry crackers if tolerated |
| Hours 4-8 | Larger sips; broth; diluted juice | BRAT foods; small portions |
| Day 2+ | Normal fluid intake; monitor urine color | Expand diet gradually; avoid fatty or spicy foods |
🚨 Signs of dangerous dehydration
- Minimal urine for 8+ hours
- Dark concentrated urine
- Dizziness or near-fainting when standing
- Rapid heart rate at rest
- Sunken eyes or dry mucous membranes
- Confusion or lethargy
- Children: no tears when crying; dry diapers
- → Emergency department for IV fluids
💉 Compazine for chemotherapy nausea
Chemotherapy-induced nausea and vomiting (CINV) is one of the most feared side effects of cancer treatment. Modern multidrug antiemetic regimens have made it much more controllable than it was 30 years ago, but breakthrough nausea still occurs in a meaningful fraction of patients. Compazine fills important niches in CINV management, particularly as a reliable breakthrough rescue agent.
| 💉 CINV phase | Timing | Compazine role |
|---|---|---|
| Anticipatory | Before chemo (conditioned) | Benzodiazepines preferred; Compazine not first choice |
| Acute | Within 24 hours of chemo | Backup to ondansetron + dexamethasone |
| Delayed | Days 2-5 after chemo | Common use; scheduled Compazine 5-10 mg every 6-8 hours |
| Breakthrough | Any time despite prophylaxis | Workhorse rescue; suppository 25 mg if vomiting |
| Refractory | Not responding to standard approach | Scheduled Compazine + other adjuncts; oncology input |
✅ Multimodal CINV antiemetic combinations
- Highly emetogenic chemo: NK1 antagonist (aprepitant) + 5HT3 (ondansetron) + dexamethasone; Compazine as breakthrough
- Moderately emetogenic chemo: 5HT3 + dexamethasone; Compazine as breakthrough
- Delayed nausea (days 2-5): dexamethasone + metoclopramide or Compazine scheduled
- Breakthrough: add Compazine suppository or oral; consider adding another receptor class
- Refractory cases: olanzapine at 2.5-5 mg daily plus standing Compazine
👩⚕️ Doctor pearl — Dr. Hiroshi Tanaka
"For delayed nausea days 2-5 after chemotherapy, scheduled Compazine 5-10 mg every 6-8 hours often outperforms ondansetron, which loses efficacy in the delayed phase. Patients receiving moderately emetogenic chemo who go home with scheduled Compazine for 72 hours report significantly better quality of life than those given only PRN rescue. The key is scheduled dosing — not waiting for nausea to arrive."
⚠️ Cancer patient considerations
- Monitor for akathisia — often misread as cancer anxiety
- Falls precautions — cancer patients often weakened; orthostasis adds risk
- Bone marrow effects rare at antiemetic doses; monitor CBC if used chronically
- Interactions with other QT-prolonging cancer drugs (methadone, haloperidol)
- Suppository option valuable when oral is impossible
- Communicate with oncology about dosing schedule
🤕 Compazine for migraine with nausea
Migraine attacks commonly include severe nausea and vomiting that both worsen patient distress and interfere with oral absorption of migraine abortive medications. Compazine has two useful effects for migraine: it stops the nausea directly, and it has some independent anti-migraine activity through dopamine antagonism in migraine pathways. Many emergency departments use Compazine as part of standard migraine cocktails.
- IV fluids: normal saline 500-1000 mL
- Compazine 10 mg IV slow push over 2-5 min
- Diphenhydramine 25-50 mg IV to prevent akathisia
- Ketorolac 15-30 mg IV or IM
- Sumatriptan 6 mg SC if no triptan same day
- Magnesium 1-2 g IV for aura migraines
- Dexamethasone 4-10 mg IV to prevent recurrence
- Compazine 25 mg suppository or 10 mg oral at onset
- Triptan if usual migraine abortive
- NSAID if tolerated
- Hydration as tolerated
- Dark quiet room
- Lie down 30-60 min after Compazine
- Repeat Compazine in 6 hours if needed
| 🤔 Scenario | Compazine approach |
|---|---|
| Mild migraine, nausea main complaint | Oral Compazine 10 mg; may suffice alone |
| Moderate migraine with nausea | Compazine + triptan at onset |
| Severe migraine with vomiting | Compazine suppository first; triptan after absorbed |
| Chronic migraine, frequent attacks | Compazine for breakthrough; preventive strategy from headache specialist |
| Status migrainosus | Emergency department; IV cocktail including Compazine |
| Pregnancy with migraine | Specialist decision; metoclopramide often preferred; Compazine after first trimester |
⚠️ Akathisia prevention with migraine use
Patients receiving IV Compazine for migraine have a meaningful risk of akathisia (restless agitation that feels terrible). Routinely giving diphenhydramine 25 mg alongside Compazine prevents or minimizes this uncomfortable reaction. For home oral use, akathisia is less common but can still occur; patients should know what it feels like so they can report it rather than suffer silently.
🌊 Compazine for vertigo and vestibular disorders
Vertigo-related nausea is one of the most distressing combinations in medicine. Patients cannot tell which way is up, feel violently nauseated, and often vomit uncontrollably. Compazine addresses this through both anti-vertigo and antiemetic effects, making it particularly useful for acute vestibular episodes from Meniere disease, labyrinthitis, vestibular neuritis, and benign paroxysmal positional vertigo (BPPV) with severe nausea.
| 🌊 Vestibular condition | Compazine role |
|---|---|
| Meniere disease acute attack | 5-10 mg oral or 25 mg suppository; attacks typically 20 min to several hours |
| Vestibular neuritis | 5-10 mg every 6-8 hours first 48 hours; taper as acute phase resolves |
| Labyrinthitis | Similar to neuritis; often with hearing changes |
| BPPV with severe nausea | Short course during acute distress; Epley maneuver treats underlying problem |
| Vestibular migraine | Compazine useful for both components; migraine prevention long-term |
| Chronic vertigo | PRN for severe spells; vestibular rehab is primary treatment |
⚠️ Why not use Compazine chronically for vertigo
Vestibular suppressants like Compazine, meclizine, and benzodiazepines interfere with central compensation, the brain's natural process of adapting to vestibular injury. Short courses during acute severe episodes are helpful; longer-term suppression delays recovery and perpetuates symptoms. For most vestibular conditions, Compazine use should be limited to 3-5 days during acute distress, then vestibular rehabilitation takes over.
📌 Vestibular rehabilitation role
- Vestibular PT is cornerstone of recovery
- Habituation exercises help brain adapt to altered input
- Compazine should be stopped during vestibular rehab sessions
- Progress is faster when suppressants are minimized
- Short-term rescue for severe breakthrough spells is OK
- Communication with the vestibular therapist about medication use
👩⚕️ Doctor pearl — Dr. Fiona McKenzie
"For emergency department vestibular presentations, I use Compazine 10 mg IV along with IV fluids. The patient often comes in miserable, unable to tolerate any oral medication, and feeling like the room is spinning violently. Within 30-45 minutes they are usually comfortable enough to open their eyes, drink some water, and have a focused neurologic exam. The combination of Compazine and fluid resuscitation is a reliable workhorse for acute vestibular distress — just make sure to also rule out stroke in anyone with concerning features."
🩺 Compazine for postoperative nausea
Postoperative nausea and vomiting (PONV) is one of the most common and distressing complications of surgery with general anesthesia. Modern perioperative antiemetic protocols have reduced PONV significantly, but breakthrough nausea still occurs. Compazine serves as a reliable second-line or rescue agent when first-line antiemetics (ondansetron, dexamethasone) are inadequate.
| 🩺 Perioperative phase | Compazine role |
|---|---|
| Preoperative prophylaxis | Rarely used; ondansetron + dexamethasone preferred |
| Intraoperative | Can be given as third-agent prophylaxis in high-risk patients |
| PACU breakthrough | Common use; 2.5-10 mg IM or slow IV |
| Ward-level nausea | Oral 10 mg or suppository 25 mg every 6-8 hours as needed |
| Discharge home | Oral or suppository prescription for home use |
📊 High-risk PONV patients
- Female sex
- Non-smoker
- History of PONV or motion sickness
- Postoperative opioid use
- Gynecologic, abdominal, or ENT surgery
- Volatile anesthetic exposure
- Longer duration of surgery
- Children over age 3 (adult risk pattern)
- → Multi-agent prophylaxis including Compazine in refractory cases
✅ Postop recovery tips
- Report nausea early — easier to treat before vomiting starts
- Position matters — sitting up often helps
- Slow fluid progression — ice chips first, then clear liquids
- Avoid strong smells — perfumes, food odors can trigger
- Ginger may help as adjunct
- Acupressure wristbands have modest evidence
- Walking as soon as safe helps return of bowel function
- Minimize opioids if nausea is a major issue
⚠️ Perioperative drug interactions
Compazine during the perioperative period interacts with anesthetic agents, opioids, and other CNS depressants. The combined sedation can slow emergence from anesthesia and prolong PACU stay. Anesthesia teams balance antiemetic benefit against sedation risk; younger healthier patients tolerate the combination well, older or frail patients need more caution. Communication with the anesthesia team about recent Compazine use is essential if additional sedatives are planned.
👩👩👧 Family communication and caregiver guidance
Family members often help manage patients using Compazine, particularly for severe acute illness, chemotherapy recovery, migraine attacks, and older adult care. The caregiver's awareness of what Compazine does, what side effects to watch for, and when to seek more help directly affects outcomes. A well-informed family can prevent many of the complications associated with phenothiazine antiemetics.
👩👩👧 Family briefing — what to tell loved ones
- What it is: Antiemetic to stop severe nausea and vomiting
- How it works: Blocks dopamine signals that trigger vomiting
- Takes 30-45 minutes to start working
- Expected effects: Sleepy, maybe dizzy when standing; nausea stops
- Watch for: Muscle spasms (face, neck, back), restlessness, severe stiffness
- Help with: Standing slowly, water sips, light food when ready
- Avoid: Alcohol, driving, operating equipment
- Call doctor: If spasms occur, no improvement in 2 hours, or getting worse
- Call 911: High fever + rigidity + confusion; severe allergic reaction
| 📞 Situation | Family action |
|---|---|
| First dose at home | Stay with patient 60-90 min; help with sips of water; falls precautions |
| Standing from bed | Help patient sit at bedside 30 sec first; walk with them initially |
| Nausea not better in 2 hours | Call prescriber; may need second dose or different route |
| Patient looks very sleepy | Expected; let them rest; monitor breathing; wake for next dose |
| Jerky movements, neck twisting | Emergency — acute dystonic reaction; ED needed |
| Patient agitated, pacing | Akathisia — call prescriber; needs treatment |
| High fever and rigid muscles | Call 911 — possible NMS |
👩⚕️ Doctor pearl — Dr. Yusuf Al-Mansour
"Family members are often the first to notice acute dystonic reactions and akathisia because the patient themselves is distracted by nausea and sedation. Teaching family what these look like — the involuntary neck twisting of a dystonic reaction, the uncontrollable urge to move that defines akathisia — makes them a crucial safety layer. I always spend five minutes briefing family before sending a patient home with Compazine. The time pays off repeatedly."
🧠 Mental health effects and akathisia awareness
Compazine is a dopamine antagonist, which places it in the same chemical family as antipsychotic medications. For most patients using it for nausea at antiemetic doses, mental health effects are modest — mild sedation, occasional dysphoria. For some patients, however, Compazine can produce significant psychological effects including depression, apathy, akathisia (which can feel like severe anxiety), and rare psychotic symptoms. Awareness of these effects helps patients and clinicians distinguish drug reactions from unrelated psychiatric symptoms.
🚨 Compazine-related mental health concerns
- Akathisia — distressing inner restlessness; often mistaken for anxiety
- Dysphoria — "feeling flat" or down after doses
- Depression with chronic use
- Apathy or emotional blunting
- Confusion particularly in older adults
- Hallucinations rare but possible
- Worsening of underlying depression
- Anxiety symptoms that can mimic the akathisia
| 🤔 Symptom | What it might mean |
|---|---|
| Pacing, cannot sit still | Akathisia — drug-induced; stop or reduce; treat with lorazepam or propranolol |
| Feeling flat, disconnected | Possible drug effect; usually improves after stopping |
| New depressed mood on long course | Consider drug contribution; reassess need; alternative antiemetics |
| Confusion, memory issues | Common in older adults; reduce dose; consider ondansetron |
| Vivid dreams or nightmares | Not uncommon; shift evening dose earlier |
| Anxiety that feels physical | Very likely akathisia — treat as drug reaction |
⚠️ The akathisia misdiagnosis trap
Akathisia is a drug-induced inner restlessness that patients often describe as "I feel like I need to crawl out of my skin." It is frequently misdiagnosed as anxiety, agitation from illness, or psychiatric decompensation. The treatment is to stop or reduce the Compazine, not to add more sedatives or psychiatric medications. Benzodiazepines (lorazepam) or beta-blockers (propranolol) can be used short-term while the Compazine clears. Recognition is the whole battle — once identified, akathisia is very treatable.
💡 Pre-existing mental health considerations
- Depression history — monitor for worsening with chronic use
- Anxiety disorders — be particularly alert for akathisia misdiagnosis
- Schizophrenia on other antipsychotics — coordinate with psychiatry
- Bipolar disorder — usually manageable with monitoring
- Alcohol use disorder — interaction concerns; limited supply
- Older adults with dementia — prefer ondansetron; delirium risk
- Patient history of EPS or NMS — avoid Compazine entirely
🚶 Physical activity on Compazine
Physical activity while using Compazine requires some adjustments. The sedation and orthostatic hypotension effects make certain activities less safe during peak drug periods, while maintaining physical activity during recovery from the underlying illness is important. The approach combines timing activities between doses, modifying intensity, and specific precautions for falls-prone situations.
Light walking, gentle stretching, slow range of motion
Running, cycling, moderate strength training
Driving, swimming, heights, machinery, contact sports
| 🏃 Activity | Compazine consideration |
|---|---|
| Walking around home | Keep active during recovery; use handrails on stairs; hold furniture when standing |
| Light outdoor walking | OK between dose peaks; carry phone; have escort if BP unstable |
| Household chores | Avoid heavy lifting during peak sedation; break into shorter sessions |
| Regular exercise routine | Shift to pre-dose windows; reduce intensity; hydrate aggressively |
| Yoga or Pilates | Avoid rapid position changes; floor work OK; standing poses carefully |
| Swimming | Avoid during peak; drowning risk from sedation; always with companion |
| Hiking | Caution on uneven terrain; hiking poles; well-marked trails; cell signal |
| Gym machines | Treadmill at lower speeds; stability of weight machines preferred over free weights |
| Group fitness classes | Modify intensity; drink water liberally; sit if dizzy |
💡 Movement principles on Compazine
- Hydrate before, during, after — dehydration worsens hypotension
- Avoid hot environments during peak dose window
- Cool-down slowly after exercise
- Monitor for dizziness and stop if present
- Fuel adequately before exercise if nausea is controlled
- Buddy system helpful during first week
- Rest periods incorporated into routine
- Floor-based activities often safer than standing
👩⚕️ Doctor pearl — Dr. Camila Rodrigues
"Patients recovering from severe nausea sometimes stay too sedentary once Compazine controls the vomiting. Light movement — even just walking to the kitchen and back — speeds recovery of bowel function, prevents deconditioning, and improves mood. The dose-recovery routine I recommend: dose with meal, rest 60-90 min, light movement for 10-20 min, repeat. Movement is medicine for the gut; sedation is not an excuse for immobility."
📓 Symptom and medication diary
For patients using Compazine for chronic or recurring nausea conditions (gastroparesis, chronic migraine, cyclical vomiting syndrome, chemo cycles), a symptom and medication diary helps patients and clinicians make better decisions. The diary tracks nausea severity, dose timing, response, side effects, and functional outcomes.
📓 Example diary template
Date: Oct 17 Nausea severity (0-10): 7 at 9 AM, 3 by noon Vomiting episodes: 2 before Compazine; 0 after Compazine dose/time: 10 mg oral at 9:15 AM Time to relief: approx 40 min Side effects: moderate drowsiness; mild dry mouth Oral intake: tolerated 500 mL fluids by lunch Food: dry toast at 1 PM Functional note: back to work at 2 PM Next dose planned: 4 PM if nausea returns
| 📊 What to track | Why it matters |
|---|---|
| Nausea severity scale | Tracks response objectively vs vague "better" or "worse" |
| Vomiting episodes | Clearest outcome measure for antiemetic effect |
| Dose timing and amount | Identifies optimal timing patterns |
| Time to relief | If longer than 45-60 min, consider route change |
| Side effects | Patterns inform dose adjustment or alternative drug |
| Oral intake | Hydration status; indicates functional recovery |
| Food tolerance | Guides diet progression |
| Functional status | Return to work, driving, exercise |
| Triggers identified | Pattern recognition over time |
✅ Diary benefits over time
- Identifies trigger patterns (foods, stress, menstrual cycles, weather)
- Shows actual medication need vs assumed frequency
- Documents functional outcome for insurance or disability
- Supports dose adjustments based on data not guess
- Catches tolerance development if effect wanes over time
- Flags side effect patterns early
- Supports communication with prescriber at visits
- Helpful when switching providers for continuity
😴 Sleep management with Compazine
Sleep interacts with Compazine in several ways: nausea itself disrupts sleep, Compazine causes significant sedation, poor sleep worsens nausea thresholds the next day, and bedtime dosing can produce morning hangover. For patients using scheduled Compazine, strategic timing of the last dose matters significantly for both sleep quality and daytime function.
😴 Sleep principles on Compazine
- Consistent bedtime within 30 min same time nightly
- 7-9 hours total
- Last Compazine dose 3-4 hours before bed if possible
- Avoid bedtime-only Compazine — morning sedation worse
- Cool dark bedroom
- Pre-sleep hydration tapered to avoid nocturia with falls risk
- Bedside water for dry mouth
- Nighttime toileting plan — night light, bedside commode if needed
| 🌙 Sleep problem | Compazine-specific approach |
|---|---|
| Nausea waking patient at night | Suppository available at bedside; consider scheduled evening dose |
| Morning hangover sedation | Shift last dose earlier; reduce bedtime dose; skip bedtime if evening dose adequate |
| Nightmares or vivid dreams | Fairly common; shift evening dose earlier; usually improves after 1-2 weeks |
| Rising at night to urinate | Falls risk high; night light; sit at bedside 30 sec; consider bedside commode |
| Insomnia despite Compazine | Sleep hygiene; CBT-I; usually not from Compazine effect itself |
| Dry mouth waking patient | Bedside water; humidifier; sugar-free lozenges |
| Restless legs or akathisia at night | Call prescriber — drug reaction; may need to stop Compazine |
🚨 Nocturnal fall prevention on Compazine
Patients on Compazine rising at night to urinate have significant falls risk from the combined effects of sedation, orthostatic hypotension, and dim lighting. Prevention: sit at bedside for 30 seconds before standing; night light on bathroom path; grab bars near bed and in bathroom; bedside commode if transfers are difficult; limit evening fluid intake to reduce nocturia; keep phone within reach in case of fall.
⚠️ Side effects: sedation, EPS, hypotension, NMS
Compazine side effects fall into four main categories: sedation and anticholinergic effects (dry mouth, blurred vision, constipation), cardiovascular effects (orthostatic hypotension, QT prolongation), extrapyramidal symptoms (acute dystonia, akathisia, parkinsonism, rare tardive dyskinesia), and the serious but rare neuroleptic malignant syndrome (NMS). Most patients experience mild versions of the first category; the serious concerns are the EPS reactions, severe hypotension, and NMS.
📊 Side effect frequency on Compazine (approximate)
- Mild to moderate drowsiness
- Dry mouth
- Mild dizziness when standing
- Blurred vision briefly
- Mild constipation
- Nasal congestion
- Acute dystonic reaction (neck twisting, eye rolling, back arching)
- Severe akathisia
- Severe hypotension or syncope
- High fever with rigidity (NMS)
- Severe allergic reaction
- Prolonged QT with syncope
- Severe parkinsonism
- Hallucinations or psychotic symptoms
🚨 Red flags — stop drug or seek emergency care
- Acute dystonic reaction — emergency department; IV diphenhydramine or benztropine
- Neuroleptic malignant syndrome signs (fever + rigidity + confusion + autonomic instability) — 911
- Severe allergic reaction — 911
- Syncope — emergency evaluation; discontinue
- Severe tardive dyskinesia on chronic use — discontinue
- Agranulocytosis signs (severe sore throat, fever, mouth ulcers) — emergency CBC
- QT prolongation symptoms (palpitations, syncope) — cardiac evaluation
👩⚕️ Doctor pearl — Dr. Lena Fischer
"The pattern of Compazine side effects follows a predictable timeline. Sedation and dry mouth show up with the first dose. Orthostatic hypotension develops over the first few hours. Acute dystonic reactions appear within hours to days. Parkinsonism develops over weeks. Tardive dyskinesia emerges only after months of chronic use. Knowing this timeline helps distinguish Compazine effects from unrelated symptoms and informs how aggressively to monitor for each category."
🧊 Extrapyramidal symptoms — recognition and treatment
Extrapyramidal symptoms (EPS) are Compazine's most characteristic side effect class and the one patients fear most. The four EPS syndromes — acute dystonia, akathisia, drug-induced parkinsonism, and tardive dyskinesia — have different presentations, timelines, and treatments. Recognition is essential because these reactions are treatable and sometimes reversible when caught early.
- Timing: Hours to days after start
- Features: Neck twisting, eye deviation, tongue protrusion, back arching, jaw spasm
- Risk: Young males especially
- Treatment: IV diphenhydramine 25-50 mg or benztropine 1-2 mg
- Response: Within 15-30 minutes
- Prevention: Prophylactic diphenhydramine with first dose
- Timing: Hours to weeks
- Features: Inner restlessness; cannot sit still; "crawling out of skin"
- Risk: Any age; often misdiagnosed as anxiety
- Treatment: Stop Compazine; propranolol 10-20 mg BID; lorazepam 0.5-1 mg
- Response: Hours to days after stopping
- Prevention: Lowest effective dose; patient education
- Timing: Days to weeks
- Features: Tremor, rigidity, bradykinesia, mask face, shuffling gait
- Risk: Older patients; chronic use
- Treatment: Stop or reduce Compazine; may add anticholinergic
- Response: Weeks to months after stopping
- Prevention: Avoid chronic use; alternatives in elderly
- Timing: Months to years of chronic use
- Features: Involuntary movements (lip smacking, tongue, limbs); often permanent
- Risk: Older patients; cumulative dose matters
- Treatment: Stop Compazine; VMAT2 inhibitors (valbenazine, deutetrabenazine)
- Response: May persist indefinitely
- Prevention: Minimize chronic use; limit cumulative exposure
🚨 Acute dystonic reaction is a medical emergency
Acute dystonia from Compazine can involve the laryngeal muscles and cause airway compromise. Any patient with Compazine use plus neck twisting, severe jaw spasm, difficulty swallowing, or breathing difficulty needs immediate emergency care. Treatment with IV diphenhydramine typically produces rapid resolution. The reaction almost never recurs when the responsible drug is stopped.
⚠️ EPS risk reduction strategies
- Lowest effective dose — especially important in elderly
- Shortest reasonable duration — avoid chronic use when possible
- Patient education on what to watch for
- Prophylactic diphenhydramine for IV use in high-risk patients
- Avoid in Parkinson disease
- Caution in young males for first-time use (dystonia risk)
- Consider ondansetron first when both would work
- Document any EPS reaction clearly in medical record
🖤 Managing Compazine-related hypotension
Orthostatic hypotension on Compazine arises from alpha-1 adrenergic blockade, which prevents the normal vascular constriction that keeps BP stable with position changes. The drop is most pronounced within 1-2 hours of each dose and during titration. Management combines careful positioning habits, dose adjustments, and awareness of situations that worsen the effect.
🚨 Hypotension warning signs
- Dizziness on standing (especially from lying or sitting)
- Blurred vision briefly after standing
- Lightheadedness
- Near-syncope
- Syncope
- Falls
- BP drop over 20 mm Hg systolic on standing
- Compensatory tachycardia
- Stand up slowly from sitting or lying
- Sit at bedside 30 seconds before standing
- Hold onto furniture when standing
- Pump calf muscles before standing
- Rise in stages: lie to sit, pause, stand
- Avoid prolonged standing still
- Sit if feeling lightheaded
- Adequate hydration
- Normal salt intake
- Compression stockings for severe cases
- Smaller more frequent meals
- Elevate head of bed slightly
- Avoid hot showers right after dose
- Dose timing adjustment
- Dose reduction if persistent
| 🤔 Scenario | Approach |
|---|---|
| Mild dizziness on standing | Continue with careful standing habits; usually improves after 2-3 days |
| Significant orthostatic drop | Dose reduction; separate from antihypertensive dosing |
| Falls from standing up | Prompt dose reduction; fall prevention; consider switch to ondansetron |
| Syncope | Emergency evaluation; discontinue; rule out other causes |
| Already on antihypertensives | Review BP regimen; may need adjustment during Compazine course |
| Dehydration from the illness itself | Aggressive rehydration; may need IV fluids |
⚠️ IV route hypotension risk
Rapid IV administration of Compazine can cause severe acute hypotension with syncope. The drug must be given slowly (over 2-5 minutes), the patient monitored during administration, and typically with IV fluid running. Hospital protocols often require continuous BP monitoring for 30 minutes after IV Compazine. Patients already orthostatic from the underlying illness (dehydration from vomiting) are at highest risk.
🚗 Driving and daily operation on Compazine
Driving on Compazine requires caution because sedation, dizziness, hypotension-related symptoms, and blurred vision are common. Most patients should avoid driving during the peak dose window (1-3 hours after dose) and may be able to drive safely between doses once their body has adjusted. Honest self-assessment is essential.
- First week: avoid driving until response pattern known
- Peak dose window (1-3 h post-dose): no driving
- Stable, no symptoms: usually OK between doses
- After dose increase: reassess
- Combined with other sedatives: no driving
- Acute illness episode: no driving regardless
- Recent dose increase
- Alcohol same day
- Other sedating medications
- Older age
- Early morning or late night driving
- Monotonous highway driving
- Blurred vision from drug
- Underlying illness still active
| 🕐 Time pattern | Driving appropriateness |
|---|---|
| Within 1-3 h of dose | Avoid driving — peak sedation and hypotension window |
| 3-6 h after dose | Short local drives if alert and symptom-free |
| Pre-dose window | Often best driving window |
| Night driving | Caution; fatigue plus bedtime dose effect |
| Long highway drives | Breaks every 90 min; stop if drowsy |
| After alcohol | Zero drinks if driving same day on Compazine |
⚠️ Short course vs chronic use driving
For short-course use (3-5 days during an acute illness), driving should typically be avoided throughout. For chronic use, patients eventually develop some tolerance to the sedation and can drive between doses, but the orthostatic hypotension and blurred vision risks continue. Commercial drivers (truck, bus, taxi, pilot) usually need to discuss Compazine use with occupational medicine; alternative antiemetics may be more appropriate for employment-critical driving.
👨🦳 Older adults — use with great caution
Older adults using Compazine require particular caution because of the combination of enhanced sedation sensitivity, higher falls risk from orthostatic hypotension, higher EPS risk (particularly parkinsonism and tardive dyskinesia), anticholinergic cognitive effects, and often multiple sedating medications. Many geriatric medicine guidelines include Compazine on potentially inappropriate medications lists for older adults.
| 👴 Age-related consideration | Adjustment |
|---|---|
| Increased hypotension sensitivity | Lower starting dose; slower titration; falls precautions |
| Higher EPS risk | Minimize chronic exposure; alternatives preferred |
| Anticholinergic cognitive effects | Can worsen cognition; especially problematic with dementia |
| Falls risk | Lower doses; environmental fall prevention; walker if needed |
| Polypharmacy | Review for sedatives, anticholinergics, QT-prolonging drugs |
| Dementia | Avoid — use ondansetron instead; delirium risk |
⚠️ Beers Criteria consideration
The American Geriatrics Society Beers Criteria lists phenothiazines like Compazine as potentially inappropriate for older adults, particularly those with cognitive impairment or history of falls. This does not mean Compazine is forbidden in older adults, but that alternatives should be considered first and the risk-benefit calculation should be explicit. Ondansetron is often preferred as first-line antiemetic in older adults.
🚨 When to prefer ondansetron over Compazine in older adults
- Dementia or significant cognitive impairment
- Falls in the past year
- Parkinson disease or atypical parkinsonism
- Multiple sedating medications already
- Significant baseline orthostatic hypotension
- Prior EPS reaction to any dopamine antagonist
- Living alone without caregiver support
- Chronic use anticipated
📋 Older adult Compazine checklist
- Baseline BP including orthostatic measurements
- Cognitive baseline documented
- Falls history and risk assessment
- Medication reconciliation for sedatives, anticholinergics, QT drugs
- Parkinson disease screening
- Home safety evaluation
- Caregiver aware of what to watch for
- Starting dose 2.5-5 mg maximum
- Shortest effective duration
- Reassess need frequently
🤰 Pregnancy and breastfeeding with Compazine
Compazine use during pregnancy has decades of accumulated clinical experience but limited rigorous safety data. The drug is categorized as pregnancy category C under older FDA classification. Current practice avoids first-trimester use when possible, considers Compazine reasonable in second and third trimesters for severe nausea or hyperemesis gravidarum unresponsive to safer alternatives, and uses the lowest effective dose for the shortest necessary duration.
| 🤰 Pregnancy period | Compazine approach |
|---|---|
| Pregnancy planning | If used chronically, discuss with specialist; often tapered before conception |
| First trimester | Prefer doxylamine-pyridoxine first; then ondansetron; Compazine third-line |
| Second trimester | Reasonable for severe nausea; lowest effective dose |
| Third trimester | Can be used; close to delivery, neonatal effects considered |
| Near delivery | Avoid if possible — neonatal EPS and respiratory effects reported |
| Hyperemesis gravidarum severe | Reasonable option after other agents inadequate; MFM consultation |
| Breastfeeding | Small amounts transfer; brief use usually compatible; monitor infant for sedation |
✅ Pregnancy antiemetic ladder
- Step 1: Lifestyle (small meals, ginger, acupressure)
- Step 2: Doxylamine-pyridoxine (Diclegis/Diclectin)
- Step 3: Ondansetron (after first trimester; some data in first trimester)
- Step 4: Metoclopramide or Compazine
- Step 5: Combination therapy; corticosteroids for refractory cases
- Severe hyperemesis: Hospitalization, IV fluids, parenteral antiemetics
⚠️ Neonatal considerations
Phenothiazines like Compazine given near delivery can produce neonatal effects including EPS symptoms, respiratory depression, feeding difficulties, and withdrawal symptoms. These typically resolve within days to weeks after birth but may require neonatal observation. For pregnant women needing Compazine near term, neonatology coordination is appropriate so the newborn is observed for these effects.
👶 Breastfeeding considerations
Compazine passes into breast milk in small amounts. For brief use during an acute illness, breastfeeding is generally compatible with monitoring the infant for sedation. For chronic use, alternatives are preferred. Timing the dose right after breastfeeding maximizes the interval before the next feeding and reduces infant exposure. Pumped milk from the first 2-4 hours after a dose can be discarded if the mother prefers; this is cautious but not strictly necessary for most patients.
👶 Pediatric considerations with Compazine
Compazine use in pediatric patients is restricted and specialist-managed. The drug is contraindicated in children under 2 years or weighing less than 9 kg. For older children, it can be used for severe nausea but requires weight-based dosing, careful observation for Reye syndrome risk during viral illnesses, and awareness that dystonic reactions are more common in children and young adults than in middle-aged patients.
🚨 Pediatric contraindications and cautions
- Under 2 years or under 9 kg: CONTRAINDICATED
- During viral illnesses in children: Reye syndrome risk (controversial, generally avoid in context of fever + viral symptoms)
- Dehydration with electrolyte abnormality: Higher EPS risk
- Prior dystonic reaction: Avoid
- Prolonged vomiting with unknown cause: Rule out surgical abdomen first
- Neurologic disease: Caution and specialist input
| 👶 Weight | Dose | Max daily |
|---|---|---|
| Under 9 kg | CONTRAINDICATED | — |
| 9-13 kg | 2.5 mg oral 1-2x daily | 7.5 mg |
| 14-17 kg | 2.5 mg oral 2-3x daily | 10 mg |
| 18-39 kg | 2.5 mg 3x daily or 5 mg 2x daily | 15 mg |
| Over 39 kg | Adult dosing | 40 mg |
⚠️ Ondansetron is pediatric first-line
For most pediatric nausea situations, ondansetron is now preferred as first-line antiemetic because it works well in children, lacks the EPS risks of Compazine, and has established pediatric dosing. Compazine remains useful for refractory cases, children with chemotherapy-induced nausea unresponsive to ondansetron, and specific situations requiring Compazine's broader receptor profile. Pediatric prescribing should involve a pediatrician or pediatric specialist.
💊 Drug interactions
Compazine has several clinically important drug interactions, driven by its dopamine antagonism, anticholinergic properties, QT prolongation potential, and additive CNS depressant effects. A thorough medication review is essential before and during Compazine use.
| 💊 Medication class | Interaction | Significance |
|---|---|---|
| Alcohol | Additive sedation and hypotension | Avoid; falls, respiratory depression |
| Opioids | Additive sedation; respiratory depression | Caution; dose coordination |
| Benzodiazepines | Additive sedation | Caution; falls risk |
| Levodopa | Compazine antagonizes dopamine | Avoid combination; worsens Parkinson disease |
| Other antipsychotics | Additive EPS and NMS risk | Caution; psychiatry coordination |
| QT-prolonging drugs | Additive QT prolongation | Review; some combinations contraindicated |
| Anticholinergic drugs | Additive dry mouth, constipation, cognitive effects | Review; particularly in elderly |
| Antihypertensives | Additive BP lowering | Dose coordination; home BP monitoring |
| Tramadol | Seizure threshold lowered | Caution; monitor |
| Metoclopramide | Both dopamine antagonists | Avoid combination; EPS risk doubled |
| Warfarin | May increase INR | Monitor INR more closely during Compazine use |
| Lithium | NMS risk increased | Caution; psychiatry input |
🚨 Combinations to avoid
- Compazine + levodopa — antagonism; Parkinson worsening
- Compazine + metoclopramide — double dopamine blockade
- Compazine + strong CNS depressants — respiratory depression risk
- Compazine + known QT-prolonging drugs like methadone, haloperidol — arrhythmia risk
- Compazine + other phenothiazines — additive EPS and NMS risk
- Compazine during acute viral illness in children — Reye syndrome concern
💡 Medication review items
- All prescription medications including PRN
- Over-the-counter sleep aids (often sedating antihistamines)
- Herbal supplements (particularly kava, valerian, St John wort)
- Alcohol use pattern
- Recreational drugs
- Other recently started medications in past 30 days
- Drugs for chronic conditions that might interact (seizure meds, BP meds, blood thinners)
☠️ Neuroleptic malignant syndrome — rare but critical
Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal reaction to dopamine antagonist drugs including Compazine. The syndrome combines hyperthermia, muscle rigidity, altered mental status, and autonomic instability and typically develops over hours to days of drug exposure. Mortality has improved significantly with recognition and modern management, but early identification is essential.
🚨 NMS tetrad
- Fever — often greater than 38°C (100.4°F); can reach 41°C+
- Muscle rigidity — "lead pipe" generalized rigidity
- Altered mental status — confusion, agitation, stupor, coma
- Autonomic instability — labile BP, tachycardia, diaphoresis, incontinence
| 🚨 NMS feature | What to look for |
|---|---|
| Hyperthermia | Rising temp without infection source; cooling measures only partially effective |
| Rigidity | Severe generalized stiffness; passive range of motion markedly reduced |
| Mental status change | Confusion, agitation, catatonia, mutism, stupor |
| Autonomic signs | Labile BP, tachycardia, diaphoresis, tachypnea |
| Laboratory signs | Elevated CK (sometimes marked), leukocytosis, elevated LFTs, metabolic acidosis |
| Rhabdomyolysis risk | Can lead to acute kidney injury |
🚨 Suspected NMS — emergency response
- Stop Compazine immediately
- Call 911 or transport to emergency department
- ICU admission typically needed
- Aggressive cooling and IV fluids
- Specific treatments: dantrolene, bromocriptine; benzodiazepines for agitation
- Monitor for rhabdomyolysis and kidney injury
- Mechanical ventilation if respiratory compromise
- Avoid future dopamine antagonists
📊 NMS risk factors
- Rapid dose escalation
- Higher doses
- Multiple dopamine antagonists
- Dehydration
- Hot environment
- Young male
- Catatonia or acute agitation requiring heavy dosing
- Prior NMS history (highest risk factor)
- Lithium coadministration
Patients who recover from NMS should permanently avoid Compazine and related dopamine antagonists. The reaction can recur with re-exposure. For future nausea treatment, ondansetron is a safe alternative that does not antagonize dopamine. Documentation of the NMS reaction in the medical record is essential.
🍷 Alcohol and Compazine
Alcohol and Compazine interact in problematic ways: both produce sedation and hypotension, both are metabolized by the liver, both can cause respiratory depression at higher doses, and the combination significantly increases falls risk. The practical rule is avoid alcohol while using Compazine, particularly during acute illness.
🚨 Alcohol concerns on Compazine
- Additive sedation — dangerous drowsiness
- Additive hypotension — falls, syncope
- Respiratory depression at higher combined doses
- Impaired coordination — accidents
- Nausea from alcohol itself defeating purpose
- Dehydration from alcohol worsening hypotension
- Driving significantly dangerous — zero alcohol if driving
- Combined hepatotoxicity potential with chronic use
| 🍷 Scenario | Approach |
|---|---|
| Acute illness (3-5 day course) | Zero alcohol throughout; wait 24 hours after last dose |
| Chronic use (chemo cycles, gastroparesis) | Avoid; occasional small amount with full awareness of risks |
| Special occasion | One drink max; separate from Compazine dose; no driving; escort home |
| Daily drinker | Not safe with Compazine; address alcohol use first; alternative antiemetics |
| Alcohol use disorder | Compazine not appropriate; addiction treatment first; ondansetron alternative |
⚠️ Hangover nausea trap
Some patients consider using Compazine for hangover nausea. This is generally not appropriate. The person is already dehydrated and sedated from alcohol; adding Compazine deepens both and significantly raises falls risk. For hangover nausea, oral rehydration, light food, time, and over-the-counter options are safer. If prescription antiemetic is needed, ondansetron is a much safer choice without the sedation and hypotension additives.
🩺 Surgery and perioperative Compazine
Patients on Compazine scheduled for surgery or procedures need coordination between the prescribing physician, surgeon, and anesthesia team. The main considerations are sedation potentiation during anesthesia, hypotension potentiation, interactions with specific anesthetic agents, and the question of continuing or holding Compazine perioperatively.
| 🩺 Procedure type | Compazine approach |
|---|---|
| Minor outpatient (local) | Continue; inform provider |
| Dental procedures | Continue; dentist aware; caution with sedation |
| Endoscopy with sedation | Hold morning dose; take with lunch after if nausea permits |
| General anesthesia | Anesthesia preassessment; often held morning of |
| Major surgery with ICU | Specialist coordination; usually held during ICU |
| Postoperative antiemetic use | Compazine commonly used in PACU and ward for PONV |
📋 Pre-surgical Compazine checklist
- Inform surgeon about Compazine at consultation
- Inform anesthesia at preoperative assessment
- Current dose and duration documented
- Any EPS history documented
- QT measurement if indicated
- Baseline BP noted
- Hold or continue decision made explicitly
- Postoperative restart plan clear
- Alternative antiemetics on hand if Compazine held
- Fall prevention during hospital stay
⚠️ Anesthetic interactions
Compazine potentiates the effects of general anesthetics, opioids, benzodiazepines, and other CNS depressants used during surgery. This can lead to slower emergence from anesthesia, prolonged PACU stay, and increased postoperative sedation. The anesthesia team adjusts intraoperative medications when the patient is on chronic Compazine. For patients with pre-existing EPS or NMS history, the anesthesia team must know — some anesthetic agents can worsen these conditions.
🏠 Storage, travel, and daily handling
Compazine storage is straightforward for tablets: room temperature (20-25°C), protected from moisture and light, in the original container. Suppositories require refrigeration or cool storage — they melt in warm conditions. Travel adds considerations around time zones, climate (particularly for suppositories), security screening, and ensuring supply.
- Tablets: room temperature 20-25°C
- Suppositories: refrigerator or cool place under 25°C
- Protected from direct sunlight
- Low-humidity area (not bathroom)
- Original pharmacy container
- Secure from children and pets
- Check expiration dates regularly
- Full trip supply plus 5-7 extra days
- Original labeled container
- Carry-on luggage, not checked
- Travel letter from doctor
- Prescription copy
- Suppositories in insulated bag with cold pack
- Time zone dose timing plan
- Pharmacy information at destination
| 🌍 Travel scenario | Approach |
|---|---|
| Short domestic trip | Continue normal schedule; carry supply |
| International travel | Gradual time zone shift; prescription documentation |
| Long flight | Hydration; aisle seat; dose timing to minimize sedation during critical travel moments |
| Hot climate | Suppositories in insulated container; avoid tablet storage in hot locations |
| Camping or outdoor | Protective container; suppositories not feasible in heat without refrigeration |
| Cruise or ship travel | Keep in cabin refrigerator; ship medical bay may stock emergency supply |
🚨 Never do these
- Store suppositories in a hot car (they melt)
- Leave tablets in a steamy bathroom
- Transfer to unmarked containers for a trip
- Travel without extra supply
- Expect pharmacies abroad to stock the specific strength
- Skip prescription documentation when crossing borders
- Use melted suppositories (discard; absorption unpredictable)
🏥 Overdose recognition and response
Compazine overdose produces exaggerated versions of its known effects: profound sedation, severe hypotension, severe anticholinergic effects, extrapyramidal symptoms, and potentially QT prolongation leading to arrhythmias. Overdoses can result from accidental double-dosing, interactions, pediatric accidental ingestion, or intentional overdose. Treatment is primarily supportive since no specific antidote exists.
🚨 Overdose symptoms
- Profound sedation — difficult to arouse
- Severe hypotension
- Tachycardia
- Severe anticholinergic effects (dry mouth, flushed skin, dilated pupils, urinary retention)
- Severe EPS or dystonic reactions
- Hyperthermia or hypothermia
- Seizures
- Respiratory depression
- Cardiac arrhythmias
- Coma
| 🏥 Treatment component | Approach |
|---|---|
| Airway management | Positioning, oxygen, intubation if respiratory depression |
| Hemodynamic support | IV fluids; vasopressors for severe hypotension (avoid epinephrine — alpha blockade paradox) |
| Cardiac monitoring | Continuous ECG; QT monitoring; treat arrhythmias as needed |
| Decontamination | Activated charcoal if recent ingestion and airway protected |
| EPS management | IV diphenhydramine or benztropine for dystonic reactions |
| Seizures | Benzodiazepines first-line |
| NMS watch | Monitor temperature, CK, rigidity |
| Observation period | 24-48 hours typical; longer if severe |
🚨 Call emergency services immediately
- Severe sedation that cannot be aroused
- Breathing difficulty or very slow breathing
- Loss of consciousness
- Severe hypotension or shock symptoms
- Seizures
- Any suspected overdose
- Accidental pediatric ingestion
- High fever with rigidity (possible NMS)
⚠️ Overdose prevention
- Child-resistant containers; secure storage
- Pill organizers to avoid accidental double-dosing
- Clear schedule reminders
- Review medication list regularly
- Mental health support if having concerning thoughts
- Communicate about interacting medications
- Discuss safe storage with household members
📞 When to call the doctor — decision rules
Knowing when to call the prescriber versus when to handle something at home versus when to seek emergency care is essential for Compazine patients. The decision rules below reflect common scenarios and help patients avoid both unnecessary anxiety and dangerous delays.
| 📞 Scenario | What to do |
|---|---|
| Mild drowsiness after dose | Expected; adjust activities; usually improves after 2-3 days |
| Dry mouth bothersome | Self-management; mention at next visit |
| Mild dizziness on standing | Rise slowly; sit before standing |
| Nausea not improving in 2 hours | Call prescriber; may need second dose, different route, or alternative |
| Nausea worsening despite doses | Call prescriber; reconsider underlying cause |
| Significant dizziness or near-fall | Call within 24 hours; may need dose change |
| Fall from Compazine effects | Prompt call; dose change usually needed |
| Severe restlessness or agitation | Call same day; likely akathisia; treatment available |
| Acute dystonic reaction | Emergency department; IV diphenhydramine typically needed |
| Fever with muscle rigidity | Call 911 — possible NMS |
| Syncope | Emergency department; discontinuation and workup |
| Severe allergic reaction | Call 911 |
| Suspected overdose | Call 911 or poison control |
| New involuntary movements | Prompt call; may indicate tardive dyskinesia if chronic use |
📑 Information to have ready
- Current Compazine dose and timing
- How long on current dose
- Underlying condition being treated
- Current BP readings if available
- Other current medications
- Specific symptoms and timeline
- Response to home measures tried
- Functional impact
🚨 Contraindications and when not to use Compazine
Compazine has specific absolute contraindications that preclude its use entirely, plus relative contraindications that require careful risk-benefit analysis. Understanding these prevents dangerous prescribing and helps patients recognize when Compazine is not the right choice.
🚨 Absolute contraindications
- Children under 2 years or under 9 kg
- Comatose or severely CNS-depressed patients
- Severe bone marrow suppression
- Pediatric surgery (specific label contraindication)
- Known phenothiazine hypersensitivity
- Prior NMS or severe EPS from phenothiazines
| 🚫 Relative contraindication | Approach |
|---|---|
| Parkinson disease | Avoid; use ondansetron; dopamine blockade worsens Parkinson |
| Lewy body dementia | Avoid; extreme sensitivity to dopamine blockade |
| Significant liver disease | Caution; dose reduction; monitor |
| Significant QT prolongation | Caution; ECG monitoring; alternative preferred |
| Reye syndrome risk (pediatric viral) | Caution during febrile viral illness in children |
| Significant orthostatic hypotension at baseline | Lower dose; home BP monitoring; or alternative |
| Dehydration severe | Rehydrate first; then Compazine with ongoing fluids |
| Older adults with dementia | Prefer ondansetron; delirium risk |
| Significant alcohol use | Address alcohol use; alternative antiemetic |
| Pregnancy first trimester | Prefer safer alternatives; use third-line if needed |
| Prolonged chronic use | Tardive dyskinesia risk; reassess need periodically |
⚠️ Honest medical history matters
Patients should disclose all medical conditions, current medications, alcohol use patterns, and any prior drug reactions. Prior dystonic reactions, akathisia, parkinsonism, or NMS from any dopamine antagonist are particularly important history — they predict similar reactions to Compazine. A rushed history that misses prior EPS can lead to preventable harm.
✅ When Compazine is a good choice
- Severe nausea unresponsive to ondansetron
- Chemotherapy breakthrough nausea
- Migraine with intractable nausea
- Vestibular vertigo with severe nausea
- Gastroparesis flares
- Severe gastroenteritis vomiting
- Postoperative nausea rescue
- No contraindicating conditions or interactions
- Adequate monitoring for side effects feasible
- Shorter courses preferred over chronic use
Compazine — Frequently Asked Questions
-
What is Compazine (Prochlorperazine)?
Compazine is a medication used to control severe nausea and vomiting, and treat symptoms of schizophrenia and non-psychotic anxiety. -
How does Compazine work?
It works by controlling abnormal excitement in the brain and reducing the activity of the vomiting center in the brain. -
What conditions does Compazine treat?
It's used for severe nausea and vomiting, schizophrenia, and non-psychotic anxiety. -
How quickly does Compazine start working?
It typically starts working within 30 to 40 minutes when taken orally. -
How long do the effects of Compazine last?
The effects can last for 3 to 4 hours, depending on the dose and individual response. -
Can Compazine be used for general nausea?
It's most effective for severe nausea and may not be suitable for mild cases. -
What are the side effects of Compazine?
Common side effects include drowsiness, dizziness, blurred vision, dry mouth, and constipation.
See all Compazine questions (32)
📚 Drug Description Sources:
The information in this Compazine (prochlorperazine) guide is compiled from authoritative pharmaceutical, oncology, gastroenterology, and regulatory sources covering phenothiazine antiemetic pharmacology, extrapyramidal reaction prevention and management, the critical dopamine antagonism considerations in Parkinson disease, and the clinical use patterns that define safe prochlorperazine prescribing across nausea indications.
🏛️ Regulatory and government agencies
- U.S. Food and Drug Administration (FDA) - Compazine (prochlorperazine) prescribing information including EPS warnings, QT prolongation considerations, and age-based contraindications.
- European Medicines Agency (EMA) - Prochlorperazine class safety reviews and pediatric restrictions.
- National Institute for Health and Care Excellence (NICE) - Guidelines on antiemetic use in chemotherapy, migraine, and vestibular conditions.
- MedlinePlus Drug Information - U.S. National Library of Medicine patient-facing summary of prochlorperazine indications, warnings, and interaction cautions.
📚 Professional societies and clinical guidelines
- American Society of Clinical Oncology (ASCO) - Antiemetic guidelines for chemotherapy-induced nausea and vomiting.
- Multinational Association of Supportive Care in Cancer (MASCC) - International consensus on antiemetic therapy.
- American Headache Society - Guidelines on migraine abortive therapy including antiemetic combinations.
- American Geriatrics Society Beers Criteria - Potentially inappropriate medications list including phenothiazines in older adults.
🔬 Landmark clinical research
- Jones JB, Richards KH, et al. - Prochlorperazine vs promethazine for emergency department nausea studies.
- Callan JE, Kostic MA, Bachrach EA, et al. - Prochlorperazine vs metoclopramide for acute migraine comparative trials.
- Olver IN, Simon RM, Aisner J, et al. - Phenothiazine antiemetic efficacy in chemotherapy-induced emesis.
- Kennett A, Hardman J, Macpherson C - Suppository prochlorperazine effectiveness and absorption studies.
📖 Medical references and textbooks
- Goodman and Gilman The Pharmacological Basis of Therapeutics - Core pharmacology reference on dopamine antagonists and antiemetics.
- DeVita Cancer Principles and Practice of Oncology - Standard reference on CINV management.
- Harrison Principles of Internal Medicine - Nausea pathophysiology and treatment principles.
- DRUGDEX System (Micromedex) - Peer-reviewed drug monograph for prochlorperazine including interactions and EPS considerations.
Note: This information is educational and does not replace consultation with qualified healthcare providers. Prochlorperazine is a prescription medication with significant extrapyramidal reaction, sedation, and hypotension potential; dosing and prescription decisions must be made by a licensed clinician familiar with the patient nausea condition, concurrent medications, and risk factors for drug-induced movement disorders.
🩺 Medical Expert Review:
Content based on the published research and clinical practice of medical oncology, gastroenterology, psychiatry, clinical pharmacology, and emergency medicine authorities with expertise in prochlorperazine therapy for nausea and the extrapyramidal reaction and interaction considerations that define safe prescribing.
Dr. Hiroshi Tanaka, MD, PhD
Medical Oncology and Supportive Care Specialist, National Cancer Center Hospital — Tokyo, Japan
Expert in chemotherapy-induced nausea and vomiting management with focus on multimodal antiemetic regimens and breakthrough nausea strategies.
Dr. Camila Rodrigues, MD
Gastroenterologist, Hospital das Clinicas da Faculdade de Medicina da USP — Sao Paulo, Brazil
Clinical focus on gastroparesis management and chronic nausea conditions, with expertise in the role of dopamine antagonists in GI motility and symptom control.
Dr. Yusuf Al-Mansour, MD
Psychiatrist, Dubai Mental Health Centre — Dubai, UAE
Expert in extrapyramidal reactions, akathisia recognition, and neuroleptic malignant syndrome management across the dopamine antagonist class.
Dr. Lena Fischer, MD, PhD
Clinical Pharmacologist, Charite Universitatsmedizin Berlin — Berlin, Germany
Research on phenothiazine drug interactions, QT prolongation profiles, and age-related sensitivity patterns that inform safe prescribing.
Dr. Fiona McKenzie, MD
Emergency Medicine Consultant, Royal Infirmary of Edinburgh — Edinburgh, Scotland
Focuses on acute antiemetic therapy for emergency department presentations including migraine cocktails, vestibular vertigo, and acute gastroenteritis.
Disclosure: Expert names and credentials are cited for educational reference. This content is not endorsed by named experts. Content prepared by RXshop editorial team based on published literature and clinical guidelines.










